|
Thursday, October 13, 2005
Cadence Pharmaceuticals Scores $25M
San Diego-based Cadence Pharmaceuticals has raised $25M in a Series A funding. The company, a specialty pharmaceuticals company, said that it raised the funding from Domain Associates, with participation by Proquest Investments, BB Biotech Ventures, CDIB BioScience Venture Management, Windamere Venture Partners, and private investors. The company is developing pharmaceuticals focused on in-hospital applications.
posted on Thursday, October 13, 2005 (Link to more information)
|
 RSS
 Email
Twitter
Previous news:
Tuesday, January 6, 2009
Monday, January 5, 2009
Friday, January 2, 2009
Wednesday, December 31, 2008
Tuesday, December 30, 2008
|
